Status:
UNKNOWN
Low Dose of Diltiazem for Rate Control of Atrial Fibrillation
Lead Sponsor:
Seoul National University Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is to show the efficacy and safety of low dose diltiazem for the treatment of atrial fibrillation with rapid ventricular response in emergency room. We will compare the standard dose of dil...
Eligibility Criteria
Inclusion
- atrial fibrillation with rapid ventricular response in emergency room
Exclusion
- age\<18
- systolic blood pressure\<90mmHg
- no consent
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT00834925
Start Date
August 1 2009
End Date
August 1 2011
Last Update
July 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea